Areas of Research
Our cancer research program addresses challenges in the treatment of many cancer types, including aggressive and intractable types of brain, breast and lung cancer.
We monitor more than 700 clinical trials, with new ones being opened every month. Our goal is to make a clinical trial available to every patient who needs one.
With more than 100 ongoing clinical trials, we are in the forefront of advancing vascular and cardiovascular medicine and surgery, continuing the legacy of Houston Methodist innovation in heart and vascular care.
We partner researchers with clinicians to develop new translational imaging materials and technologies that produce the innovative visualization techniques responsible for improving patient diagnosis, therapy and outcomes.
In the areas of immunology and inflammation, we perform interdisciplinary translational research that bridges laboratory science and clinical applications in the fields of cardiovascular disease, infectious and autoimmune disease, digestive disorders, cancer, neuroscience and transplantation
We focus our research on infectious diseases that are significant challenges in health care today, including sepsis, group A Streptococcus and tuberculosis.
We provide the infrastructure for the development of fundamental platforms, including silicon and semiconductors, nano- and micro-fabrication, mathematics, molecular medicine and pharmaceutical technologies.
We conduct meaningful and pioneering translational research in neurosciences, including both bench science and clinical trials, that broadens our understanding of diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy and spinal disorders.
At Houston Methodist, we explore new techniques and devices to learn how to provide personalized care from diagnosis through rehabilitation for musculoskeletal conditions such as trauma, sports injuries, degenerative diseases, infections, tumors and congenital disorders.
Our investigations are designed to help develop research expertise and provide national leadership that will pave the way to fundamental improvements in patient outcomes throughout the world.
Our goal is to advance the field of biotherapeutics to treat neurodegenerative, urological, orthopedic and cardiovascular disorders and improve transplantation outcomes.
We focus on research that can minimize postoperative complications for heart, lung, liver, kidney and other organ transplantation, with a strong emphasis on immunological and biotherapeutic approaches to the preservation and protection of organ transplants.